This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Barclays analyst Matt Miksic initiated coverage on Abbott Laboratories (NYSE: ABT) with an Overweight rating and set a price target of $120. Abbott's shares closed at $98.16 on Tuesday, indicating potential upside based on the new target. This initiation is part of a broader trend of analysts adjusting their ratings on various companies, including Honeywell Aerospace and M&T Bank Corporation.